Fiscal Period | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|
Period End Date | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
Cash Equivalents | 12.09 | 9.98 | - | 0.00 |
Short Term Investments | 3.97 | 3.77 | 34.06 | 45.14 |
Cashand Short Term Investments | 16.06 | 13.75 | 37.45 | 46.81 |
Accounts Receivable- Trade Net | 141.42 | 112.41 | 75.10 | 68.18 |
Total Receivables Net | 141.81 | 112.48 | 80.60 | 76.23 |
Total Inventory | 61.47 | 37.84 | 23.08 | 23.72 |
Other Current Assets Total | 40.57 | 20.22 | 1.26 | 0.74 |
Total Current Assets | 259.91 | 184.29 | 143.74 | 148.02 |
Property/ Plant/ Equipment Total- Net | 233.37 | 140.20 | 65.41 | 43.80 |
Intangibles Net | 1.04 | - | - | - |
Long Term Investments | 3.98 | 4.20 | 4.09 | 4.06 |
Other Long Term Assets Total | 5.52 | 21.65 | 0.00 | 0.00 |
Total Assets | 503.82 | 350.34 | 226.06 | 198.65 |
Accounts Payable | 60.04 | 58.37 | 23.76 | 26.17 |
Current Portof LT Debt/ Capital Leases | 84.42 | 38.82 | 2.48 | 2.46 |
Other Currentliabilities Total | 45.94 | 22.60 | 11.66 | 12.90 |
Total Current Liabilities | 190.40 | 119.79 | 41.53 | 43.63 |
Long Term Debt | 73.16 | 10.92 | 12.21 | 8.08 |
Total Long Term Debt | 73.16 | 10.92 | 12.49 | 8.59 |
Total Debt | 157.58 | 49.74 | 17.75 | 12.24 |
Deferred Income Tax | 0.00 | 0.40 | 0.96 | 1.97 |
Minority Interest | 40.91 | 35.10 | 4.32 | -0.05 |
Other Liabilities Total | 2.09 | 1.33 | 0.94 | 0.64 |
Total Liabilities | 306.56 | 167.54 | 60.23 | 54.78 |
Common Stock Total | 5.82 | 5.77 | 5.77 | 5.73 |
Other Equity Total | 191.44 | 177.03 | - | 0.00 |
Total Equity | 197.26 | 182.80 | 165.83 | 143.87 |
Total Liabilities Shareholders' Equity | 503.82 | 350.34 | 226.06 | 198.65 |
Total Common Shares Outstanding | 0.58 | 0.58 | 0.58 | 0.57 |
Tangible Book Valueper Share Common Eq | 337.17 | 316.81 | 287.16 | 251.09 |
Property/ Plant/ Equipment Total- Gross | - | 99.01 | 98.63 | 71.49 |
Cash | - | - | 3.40 | 1.68 |
Prepaid Expenses | - | - | 1.33 | 0.52 |
Accumulated Depreciation Total | - | - | -33.22 | -27.69 |
Note Receivable- Long Term | - | - | 12.82 | 2.77 |
Accrued Expenses | - | - | 0.85 | 0.91 |
Notes Payable/ Short Term Debt | - | - | 2.78 | 1.19 |
Capital Lease Obligations | - | - | 0.28 | 0.51 |
Additional Paid- In Capital | - | - | 1.52 | - |
Retained Earnings( Accumulated Deficit) | - | - | 158.53 | 138.14 |
Bharat Parenterals Dividend Bharat Parenterals Bonus Bharat Parenterals News Bharat Parenterals AGM Bharat Parenterals Rights Bharat Parenterals Splits Bharat Parenterals Board Meetings Bharat Parenterals Key Metrics Bharat Parenterals Shareholdings Bharat Parenterals Profit Loss Bharat Parenterals Cashflow Bharat Parenterals Q1 Results Bharat Parenterals Q2 Results Bharat Parenterals Q3 Results Bharat Parenterals Q4 Results
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks